[go: up one dir, main page]

ZA200603810B - Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
ZA200603810B
ZA200603810B ZA200603810A ZA200603810A ZA200603810B ZA 200603810 B ZA200603810 B ZA 200603810B ZA 200603810 A ZA200603810 A ZA 200603810A ZA 200603810 A ZA200603810 A ZA 200603810A ZA 200603810 B ZA200603810 B ZA 200603810B
Authority
ZA
South Africa
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
phenylpyridylpiperazine
compounds
Prior art date
Application number
ZA200603810A
Other languages
English (en)
Inventor
Desos Patrice
Cordi Alexis
Lestage Pierre
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of ZA200603810B publication Critical patent/ZA200603810B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
ZA200603810A 2005-05-12 2006-05-12 Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them ZA200603810B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504758A FR2885616B1 (fr) 2005-05-12 2005-05-12 Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA200603810B true ZA200603810B (en) 2007-08-29

Family

ID=35668833

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200603810A ZA200603810B (en) 2005-05-12 2006-05-12 Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (1) US7494994B2 (xx)
EP (1) EP1721897A1 (xx)
JP (1) JP2006316061A (xx)
KR (1) KR100807481B1 (xx)
CN (1) CN100569767C (xx)
AP (1) AP2007004223A0 (xx)
AR (1) AR054121A1 (xx)
AU (1) AU2006201994A1 (xx)
BR (1) BRPI0601773A (xx)
CA (1) CA2546392A1 (xx)
CR (1) CR9499A (xx)
EA (1) EA011155B1 (xx)
FR (1) FR2885616B1 (xx)
GE (1) GEP20084470B (xx)
GT (1) GT200700097A (xx)
IL (1) IL186862A0 (xx)
MA (1) MA28326A1 (xx)
MY (1) MY141784A (xx)
NO (1) NO20062083L (xx)
NZ (1) NZ547122A (xx)
SG (1) SG127801A1 (xx)
TN (1) TNSN07395A1 (xx)
UA (1) UA87284C2 (xx)
WO (1) WO2006120349A1 (xx)
ZA (1) ZA200603810B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236259A1 (en) * 2002-02-05 2003-12-25 Rolf Hohlweg Novel aryl- and heteroarylpiperazines
KR101286569B1 (ko) 2005-07-04 2013-07-23 하이 포인트 파마슈티칼스, 엘엘씨 신규 약제
CN102295606A (zh) 2006-05-29 2011-12-28 高点制药有限责任公司 合成3-(1,3-苯并间二氧杂环戊烯-5-基)-6-(4-环丙基哌嗪-1-基)-哒嗪的方法及其适用的中间体
CN101605767A (zh) * 2006-12-14 2009-12-16 詹森药业有限公司 制备哌嗪基苯甲酰胺衍生物和二氮杂环庚烷基苯甲酰胺衍生物的方法
EP2014656A3 (en) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
DK2678327T3 (en) 2011-02-23 2016-12-12 Lupin Ltd Heteroaryl derivatives which ALFA7 nAChR modulators
CA2866015A1 (en) 2012-03-06 2013-09-12 Lupin Limited Thiazole derivatives as alpha 7 nachr modulators
US10239849B2 (en) * 2015-11-12 2019-03-26 Merck Sharp & Dohme Corp. Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
WO1992005156A1 (en) * 1990-09-13 1992-04-02 Smithkline Beecham Corporation Pyridylthio or pyridyloxy alkanoic acids
EP0934312B1 (en) * 1996-10-04 2003-03-19 Novo Nordisk A/S 1,4-disubstituted piperazines
EP1020445B1 (en) * 1997-10-02 2008-08-13 Eisai R&D Management Co., Ltd. Fused pyridine derivatives
PT1027336E (pt) * 1997-10-27 2005-01-31 Neurosearch As Heteroarildiazacicloalcanos como ligandos colinergicos de receptores nocotinicos de acetilcolina
GB9919776D0 (en) * 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds
US20030236259A1 (en) * 2002-02-05 2003-12-25 Rolf Hohlweg Novel aryl- and heteroarylpiperazines

Also Published As

Publication number Publication date
CN1896073A (zh) 2007-01-17
AP2007004223A0 (en) 2007-10-31
CN100569767C (zh) 2009-12-16
CR9499A (es) 2008-02-20
IL186862A0 (en) 2008-02-09
UA87284C2 (ru) 2009-07-10
AU2006201994A1 (en) 2006-11-30
US7494994B2 (en) 2009-02-24
GEP20084470B (en) 2008-08-25
EP1721897A1 (fr) 2006-11-15
MY141784A (en) 2010-06-30
KR20060117263A (ko) 2006-11-16
GT200700097A (es) 2009-06-04
EA200600760A1 (ru) 2006-12-29
BRPI0601773A (pt) 2007-05-15
NZ547122A (en) 2007-05-31
JP2006316061A (ja) 2006-11-24
AR054121A1 (es) 2007-06-06
MA28326A1 (fr) 2006-12-01
NO20062083L (no) 2006-11-13
FR2885616B1 (fr) 2007-06-22
WO2006120349A1 (fr) 2006-11-16
US20060258670A1 (en) 2006-11-16
TNSN07395A1 (en) 2009-03-17
SG127801A1 (en) 2006-12-29
FR2885616A1 (fr) 2006-11-17
CA2546392A1 (fr) 2006-11-12
EA011155B1 (ru) 2009-02-27
KR100807481B1 (ko) 2008-02-25

Similar Documents

Publication Publication Date Title
ZA200704957B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
AP2384A (en) 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
SG131857A1 (en) δD-CRYSTALLINE FORM OF IV ABRADINE HYDROCHLORIDE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
IL173957A0 (en) ??-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
IL178544A0 (en) ??-crystalline form of ivabradine hydrochlorioe, a process for its preparation and pharmaceutical compositions containing it
AP2006003521A0 (en) Y-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it.
IL173958A0 (en) ??d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
IL184562A (en) Polymorph ivandront a, a process for its preparation and pharmaceutical preparations containing it
IL173960A0 (en) ??d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
ZA200801103B (en) Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them
EP1871363A4 (en) COMBINED STAGE PROCESS FOR PHARMACEUTICAL COMPOSITIONS
IL186862A0 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
LT1729739T (lt) Kietos farmacinės kompozicijos gamybos būdas
ZA200602631B (en) Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200801991B (en) Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds
ZA200806399B (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
ZA200704955B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
SG121999A1 (en) New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200603809B (en) Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704956B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200602872B (en) Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200800833B (en) New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
SG110170A1 (en) New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200606276B (en) Polysubstituted 1,1-pyridylaminocyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200606277B (en) Polysubstituted 1,1-pyridyloxycyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them